openPR Logo
Press release

Germany Healthcare Outlook Report, 2022 | DelveInsight

06-02-2022 12:13 PM CET | Health & Medicine

Press release from: DelveInsight Business Research

Germany Healthcare Outlook

Germany Healthcare Outlook

DelveInsight's, "Germany Healthcare Outlook Report, 2022," report provides comprehensive insights into the healthcare scenario, regulatory policies, and reimbursement landscape in Germany. The report also identifies key trends in the healthcare market and provides insights into the demographic and healthcare infrastructure of the country. Along with this the report also provides a brief look into the trends and segmentation of the pharmaceutical and medical devices market in Germany.

As per DelveInsight's analysis, some of the best-known medical device manufacturers are based in Germany, and some major players from around the world have operations in Germany. However, small- to mid-sized medical device companies make up the majority of the industry. Germany is an attractive market due to its consistent growth and sophisticated approach to healthcare. Demand for highly innovative technologies and diagnostic, therapeutic, and minimally invasive equipment remains high. Many German manufacturers export their products, leaving an opportunity for foreign importers to capitalize on these demands.

Learn more about key trends in the Germany Healthcare Market @ https://www.delveinsight.com/report-store/germany-healthcare-outlook-report?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr

Germany Healthcare Outlook

Germany officially the Federal Republic of Germany is a country in Central and Western Europe with 83.2 million people, distributed on a territory of 357,022 square kilometers. In 2019, GDP growth for Germany was 0.6 %. Germany has a universal multi-payer health care system. It encompasses both statutory health insurance for people who earn less than a certain salary, as well as private health insurance for those who earn more and choose to purchase their own. Health insurance is provided by two subsystems: statutory health insurance (SHI), consisting of competing, not-for-profit, nongovernmental health insurance plans known as sickness funds; and private health insurance. Long-term care services are covered separately under Germany's mandatory, statutory long-term care insurance (LTCI). Unlike those in many other countries, sickness funds and private health insurers, as well as long-term care insurers, use the same providers. In other words, hospitals and physicians treat all patients regardless of whether they have SHI or private insurance.

Employers and their employees pay for most of the health care system in Germany through premiums. All workers contribute about 7.5 percent of their salary to a public health insurance pool. Employers match that 7.5 percent contribution. The ideology lives on in the modern German system. Everyone covered by statutory insurance has an equal right to medical care. And the system imposes strict limits on out-of-pocket costs, greatly reducing the number of surprise medical bills.

Germany Industry Overview Chapter

1. Pharmaceutical

The German pharmaceutical market is the largest in Europe and the fourth largest in the world. 1170 pharmaceutical and biotechnology companies with more than 128,000 workers (2015) operate in Germany. In addition to globally successful enterprises, the industry composed of more than 800 medium-sized businesses and young biotech companies. German companies invest $6.5 billion (2016) annually in research and development. Within Europe, Germany is the leading market for non-prescription medicines products.

2. Medical Device

The German medical device market is the largest in Europe and the third-largest in the world. It was valued at $26 billion in 2014 and continues to grow despite a sluggish European economy. Germany has become one of the world's most important countries for clinical studies. Germany is the leader in industry-initiated clinical studies in Europe and second worldwide. The dense network of universities and faculties as well as a variety of research institutions not affiliated to universities speak in favor of Germany as a business location.

Apart from this, the report covers some latest information on the COVID 19 update and the future of healthcare technology in Germany.

Learn how the Germany Healthcare market is growing in the Pharmaceutical and Medical Device sector @ https://www.delveinsight.com/report-store/germany-healthcare-outlook-report?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr

Germany Healthcare Outlook Report Highlights

1. Overview of the pharmaceutical and medical device markets

2. An insightful review of the reimbursement and regulatory landscape, covering the healthcare reimbursement process, regulatory agencies, and the approval processes for new drugs and medical devices

3. Detailed analysis of the political and economic environment, including economic indicators, demographics, healthcare infrastructure, and healthcare expenditure

4. An overview of the opportunities for and challenges to growth in the healthcare market

Request for a detailed sample report @ https://www.delveinsight.com/sample-request/germany-healthcare-outlook-report?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr

Germany Healthcare Outlook Key Players

Major key companies involved in the Germany Healthcare market are Fresenius AG, Bayer AG, Evotec AG, Boehringer Ingelheim, Merck KGaA, Helios Kliniken GmbH, Sandoz International GmbH, Symrise AG, Alexianer GmbH, TÜV NORD Group, and others.

Learn more about the key companies at:
https://www.delveinsight.com/report-store/germany-healthcare-outlook-report?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr

Table of contents

1. Key Insights

2. Germany at a Glance

3. Executive Summary

4. Assessment

5. Market Access

6. Germany PESTLE Analysis

7. Driver and Barriers

8. Appendix

9. References

10. DelveInsight Capabilities

11. Disclaimer

12. About DelveInsight

Get the Detailed TOC of the Germany Healthcare Outlook Report here:
https://www.delveinsight.com/report-store/germany-healthcare-outlook-report?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr

About DelveInsight

DelveInsight is a leading Life Science market research and business consulting company recognized for its off-the-shelf syndicated market research reports and customized solutions to firms in the healthcare sector.

Contact Us:

Kritika Rehani
info@delveinsight.com
+1(919)321-6187
www.delveinsight.com

304 S. Jones Blvd #2432, Las Vegas NV 89107

DelveInsight is a leading Life Science market research and business consulting company recognized for its off-the-shelf syndicated market research reports and customized solutions to firms in the healthcare sector.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Germany Healthcare Outlook Report, 2022 | DelveInsight here

News-ID: 2643529 • Views:

More Releases from DelveInsight Business Research

Pharma Asset Management Success Story: Strategic In-Licensing in the Atrial Fibrillation Space by DelveInsight
Pharma Asset Management Success Story: Strategic In-Licensing in the Atrial Fibr …
DelveInsight, a leading business consulting and market research firm, is pleased to announce the successful completion of an Asset Prioritization project that enabled a mid-sized pharmaceutical client to identify, evaluate, and secure a high-value therapeutic asset for in-licensing in the Atrial Fibrillation (AF) space. The case study highlights how evidence-based insights, structured methodologies, and multi-layered evaluations supported the client in achieving its long-term strategic growth goals. Objective of the Case Study The
Myopia Clinical Trials Outlook 2025: Competitive Landscape, Regulatory Milestones, Therapies in Development, Mechanisms of Action, and Routes of Administration - By DelveInsight
Myopia Clinical Trials Outlook 2025: Competitive Landscape, Regulatory Milestone …
(Albany, USA) - DelveInsight's newly released report, "Myopia Pipeline Insight 2025," delivers an in-depth assessment of the clinical trial landscape, regulatory progress, and therapeutic development trends shaping the Myopia therapeutics market. The analysis highlights ongoing clinical advancements, pipeline opportunities, and the potential impact of emerging therapies on patient care and market dynamics. According to DelveInsight's evaluation, the Myopia pipeline remains highly active, with 8+ pharmaceutical and biotechnology companies investigating more than
Global Biopsy Devices Market to Reach USD 10.81 Billion by 2032, Driven by Rising Cancer Burden and Technological Advancements, states DelveInsight
Global Biopsy Devices Market to Reach USD 10.81 Billion by 2032, Driven by Risin …
The global biopsy devices market is poised for significant growth, with market size projected to increase from USD 5,813.16 million in 2024 to USD 10,812.77 million by 2032, expanding at a CAGR of 8.09% during 2025-2032. The robust expansion is being driven by the growing incidence of cancers, rising demand for minimally invasive diagnostic procedures, and rapid advancements in biopsy technologies. Biopsy devices play a crucial role in disease diagnosis by
Global General Surgery Devices Market to Reach USD 35.4 Billion by 2032, Driven by Rising Surgical Procedures, Technological Advancements, and Growing Adoption of Minimally Invasive Techniques, States DelveInsight
Global General Surgery Devices Market to Reach USD 35.4 Billion by 2032, Driven …
According to the latest market analysis, the global general surgery devices market is set for robust growth, increasing from USD 21,786.29 million in 2024 to USD 35,399.63 million by 2032, expanding at a CAGR of 6.34% during 2025-2032. This growth reflects a surge in surgical procedures, continuous technological advancements, and rising demand for minimally invasive and robotic-assisted surgical techniques across healthcare systems worldwide. DelveInsight's General Surgery Devices Market Report 2032 provides

All 5 Releases


More Releases for German

Elan German Transforms Language Learning Journey for Professionals and Students …
Leading Institute Bridges Language Barriers with Comprehensive A1-B2 Programs, Corporate Training, and Complete Relocation Support The German language opens doors to Europe's largest economy, world-class universities, and countless career opportunities. Yet many learners struggle with traditional methods that focus on textbook German rather than real-world communication skills. Elan German is changing that narrative. This specialised language training institute has built its reputation on a simple premise: German fluency isn't just about grammar
Find the best conditions for your German mortgage with Your German Mortgage
During times of the Coronavirus, we are here to help you with finding the right financing for your property. Special times call for special measures, that's why it's now more important to find a trustworthy and experienced mortgage broker than ever. We got you covered from finding your property of dreams all the way to financing it. To ensure that, we have experts in almost every German major city,
German Maritime Security 2018, German Government Statement!
Despite all international and national efforts, piracy remains a serious peril for the international shipping industry. Especially in Asia (i.e. Chittagong/Bangladesh or on the Strait of Malacca), but also in South America (e.g. Bay of Santos/Brazil or in the port of Callao/Peru) robbery or piracy there has recurred in the recent past. At the West African coast the number of incidents had raised even by 50% with 66 incidents this
German Local Trade Tax
All the companies in Germany are liable to pay not only corporate income tax, whose rate is nowadays about 15% of the annual profit of the company, but also trade tax (Gewerbesteuer), which is a tax of German characteristics. Why would we say that trade tax is of German characteristics? Because it is different from the corporate income tax, which is charged by the German Federal Government and it is difficult
Integral Launches German Bureau
Integral Launches German Bureau Appoints Suchit Manchanda as the Head of Operations January 4, 2010: Germany: Integral Fusion, a leading software services firm, has launched operations in Germany and announced the appointment of Suchit Manchanda as their Managing Director. The German bureau will be responsible for strategic business development in European Union organizations and client servicing. Suchit a world class MBA from Hochschule Nürnberg, Germany and a Masters in IT from Jamia
ISPA – German Masters 2008
Magdeburg – Over the long weekend of the 4. Mai more than 1.000 Skat players filled the Mittelland hall in Barleben. The tournaments of the 30. German Mastery and the 27. open International German Single Mastership were held by the International Skat Players Association, ISPA Germany. Patrons of the Games were the 1st Barleber Skat sports club e.V. and the Skat club \"Burger Ihleskater\", whose good organization together with the